ATE152732T1 - Neue synthetische peptide mit immunomodulatorischer wirkung und deren herstellung - Google Patents

Neue synthetische peptide mit immunomodulatorischer wirkung und deren herstellung

Info

Publication number
ATE152732T1
ATE152732T1 AT92902251T AT92902251T ATE152732T1 AT E152732 T1 ATE152732 T1 AT E152732T1 AT 92902251 T AT92902251 T AT 92902251T AT 92902251 T AT92902251 T AT 92902251T AT E152732 T1 ATE152732 T1 AT E152732T1
Authority
AT
Austria
Prior art keywords
peptides
residue
cells
aminoacid
production
Prior art date
Application number
AT92902251T
Other languages
English (en)
Inventor
Calvo Esteban Santiago
Bados Maria Luisa Subira
Masllorens Antonio Brugarolas
Moratalla Natalia Lopez
Zabalza Maria Jesus Lopez
Algarra Salvador Martin
Cuesta Francisco Borras
Original Assignee
Inst Cientifico Tecnol Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Cientifico Tecnol Navarra filed Critical Inst Cientifico Tecnol Navarra
Application granted granted Critical
Publication of ATE152732T1 publication Critical patent/ATE152732T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92902251T 1990-12-27 1991-12-18 Neue synthetische peptide mit immunomodulatorischer wirkung und deren herstellung ATE152732T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909028097A GB9028097D0 (en) 1990-12-27 1990-12-27 New synthetic peptides active as immunomodulators

Publications (1)

Publication Number Publication Date
ATE152732T1 true ATE152732T1 (de) 1997-05-15

Family

ID=10687626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902251T ATE152732T1 (de) 1990-12-27 1991-12-18 Neue synthetische peptide mit immunomodulatorischer wirkung und deren herstellung

Country Status (8)

Country Link
EP (1) EP0532716B1 (de)
JP (1) JPH05504974A (de)
AT (1) ATE152732T1 (de)
AU (1) AU640846B2 (de)
CA (1) CA2076877A1 (de)
DE (1) DE69126023D1 (de)
GB (1) GB9028097D0 (de)
WO (1) WO1992012171A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides

Also Published As

Publication number Publication date
JPH05504974A (ja) 1993-07-29
EP0532716B1 (de) 1997-05-07
AU640846B2 (en) 1993-09-02
WO1992012171A1 (es) 1992-07-23
AU9126391A (en) 1992-08-17
CA2076877A1 (en) 1992-06-28
DE69126023D1 (de) 1997-06-12
EP0532716A1 (de) 1993-03-24
GB9028097D0 (en) 1991-02-13

Similar Documents

Publication Publication Date Title
AU566180B2 (en) Human pancreatic grf
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
AU531556B2 (en) Tripeptides
KR100295606B1 (de)
ATE152732T1 (de) Neue synthetische peptide mit immunomodulatorischer wirkung und deren herstellung
DE69120776T2 (de) Neue inhibitorische Peptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties